Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 241-620-3 | CAS number: 17636-10-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: dermal
Administrative data
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: GLP-study with minor deficiencies in the report details
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 987
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- no
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- other: "Appraisal for the Safety of Chemicals in Foods, Drugs and Cosmetics", by the Staff of the Division of Pharmacology, FDA 1959
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- Sodium 3-mercaptopropanesulphonate
- EC Number:
- 241-620-3
- EC Name:
- Sodium 3-mercaptopropanesulphonate
- Cas Number:
- 17636-10-1
- Molecular formula:
- C3H8O3S2.Na
- IUPAC Name:
- sodium 3-sulfanylpropane-1-sulfonate
- Details on test material:
- - Name of test material (as cited in study report): 3-Mercaptopropansulfonsaures Natrium (MPS)
- Name of test material: 1-Propanesulfonic acid, 3-mercapto-, monosodium salt
- Substance type: organic salt
- Physical state: white powder
- Lot/batch No.: 43 399
- Other: for the experiment, the substance was applied 1 : 1 in water.
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: SPF-Wistar rats (breeding Winkelmann, Paderborn, Germany)
- Weight at study initiation: ca. 210 g
- Housing: animals were kept in groups of 5 males and 5 females (divided at random) in individual cages
- Diet (e.g. ad libitum): laboratory standard diet (Altromin, Lage)
- Water (e.g. ad libitum): ad libitum
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ° C ± 2 ° C
- Humidity (%): 50 - 60%
- Photoperiod (hrs dark / hrs light): daily lighting for 12 hours.
Administration / exposure
- Type of coverage:
- semiocclusive
- Vehicle:
- water
- Remarks:
- the product was diluted 1 to 1 with water, prior to application
- Details on dermal exposure:
- For reasons of optimal application of the substance and to allow good skin contact, the animals were shaved completely on the back. The entire trunk was wrapped with two layers of gauze and the undiluted substance was applied to the shaved localization. The treated area was covered with a thin plastic shell and coated with Stülpa. To avoid slipping, the whole body was bonded with adhesive tape, avoiding simultaneously oral ingestion and dehydration of the 1: 1 in water applied substance. The animals were left for 24 hours in this manner. Then the animals were carefully "unpacked" and cleaned with a wet, very warm cloth. The completely wet animals were individually dried by a hairdryer and only after reaching the "optimal cleaned" state, were put in individual farming. After dermal administration, the animals were observed individually housed for 14 days, were they were evaluated using as criteria, the symptoms of poisoning, the clinical behaviour and mortality.
- Duration of exposure:
- 24 h
- Doses:
- 2.5, 5.0 and 7.5 g/kg bw
- No. of animals per sex per dose:
- 5 males and females per dose
- Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: observations were conducted after 24 h, 48 h, after 7 and after 14 days, weighing was done at the beginning and the end of the study
- Necropsy of survivors performed: yes/no: yes (macroscopically examined for pathological changes)
- Other examinations performed: clinical signs, body weights - Statistics:
- No data given on statistical methods
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 7.5 other: g/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: No animals died
- Mortality:
- No mortalities occurred.
- Clinical signs:
- other: The animals behaved after the application a little more quiet than normal, which can be attributed to the bandage. After unpacking and in the further following-up period, the animals behaved physiologically.
- Gross pathology:
- In the end section no macroscopic anatomical or pathological findings in the belly, chest and skull were noted.
At the treated spinal sites there were no deviations from normal findings. The dorsal skin appeared subjectively in the highest dose group a little dry or leathery. - Other findings:
- no data
Any other information on results incl. tables
Table 1: weekly protocol for clinical observations - group 1
testing period: 7 / 14 days p.a., group: I = 2,5 g/kg animal-no.:1-10 | |
Sex: 5 m + 5 f | |
examination (macroscopically) | summary of findings |
Appearance/ behaviour | physiological |
reflexes | physiological without special findings |
fur and skin turgor | physiological, hair was growing evenly |
orifices | physiological without special findings |
faeces (colour and consistency) | physiological without special findings |
body weight / food and water intake | normal body weight gain, normal food and water intake |
acute symptoms | none |
Table 2: weekly protocol for clinical observations - group 2
testing period: 7 / 14 days p.a., group: II = 5,0 g/kg animal-no.:1-10 | |
Sex: 5 m + 5 f | |
examination (macroscopically) | summary of findings |
Appearance/ behaviour | physiological |
reflexes | physiological without special findings |
fur and skin turgor | physiological, hair was growing evenly |
orifices | physiological without special findings |
faeces (colour and consistency) | physiological without special findings |
body weight / food and water intake | normal body weight gain, normal food and water intake |
acute symptoms | none |
Table 3: weekly protocol for clinical observations - group 3
testing period: 7 / 14 days p.a., group: III = 7,5 g/kg animal-no.:1-10 | |
Sex: 5 m + 5 f | |
examination (macroscopically) | summary of findings |
Appearance/ behaviour | physiological |
reflexes | physiological without special findings |
fur and skin turgor | physiological, hair was growing evenly |
orifices | physiological without special findings |
faeces (colour and consistency) | physiological without special findings |
body weight / food and water intake | normal body weight gain, normal food and water intake |
acute symptoms | none |
Applicant's summary and conclusion
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The study was performed according to the OECD Guideline 402 without deviations and therefore considered to be of the highest quality (reliability Klimisch 1).The validity criteria of the test system was fulfilled. The test material did not induce any signs of acute dermal toxicity. The test material was considered to be not toxic via the dermal exposure route under the conditions of the test, which is based on the LD50 values derived from this study (LD50 > 7.5 g/kg bw).
- Executive summary:
The acute dermal toxicity of 1-Propanesulfonic acid, 3-mercapto-, monosodium salt (MPS) was investigated in rats (Dickhaus and Heisler, 1987). The substance was applied under semi-occlusive conditions to the skin for 24 h. No mortalities occurred and no clinical signs were reported. Therefore the test substance has an LD50 > 7.5 g/kg bw and can be regarded as non-toxic via the dermal exposure route.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
